The current study was devised to evaluate the therapeutic potential of exte
nded surgery for improving survival in undifferentiated thyroid carcinoma (
UTC). An institutional retrospective survival analysis (July 1994 to Decemb
er 1998) of 30 patients who underwent surgery for UTC with locally curative
intent was done. Median anti 1-year survival was 4 months and 37%, respect
ively. Primary patients were older (70 vs. 59 years; p = 0.026) and decease
d earlier (median survival 4 vs. 20 months; p = 0.027, log-rank test) than
their reoperative counterparts, suggesting a referral bias toward younger p
atients. Survival analysis was restricted to primary pT4 UTC, leaving 18 pa
tients. On univariate analysis, pN and M category, degree of resection (R2
versus R0/1 and radiotherapy (0-30 Gy versus > 30 Gy) were identified as pa
rameters suitable for further testing. On multivariate analysis, pN1 was a
significant prognosticator of decreased survival (RR = 5.9; p = 0.043), fol
lowed by R2 (RR = 4.1, p = 0.088) and MZ (RR = 3.6; p = 0.089). Because of
low patient numbers after stratification for radiotherapy, only pN and degr
ee of resection were analyzed on subsequent multivariate analysis. Ln the i
ncomplete radiotherapy stratum, neither of the two parameters affected surv
ival, whereas R2 and pN1 limited survival in the complete radiotherapy stra
tum. In primary pT4 UTC, a subset of pNO patients with R0/1 resections and
radiotherapy greater than 30 Gy seemed to benefit from extended surgery. Be
cause pN1 and R2 patients with radiotherapy of 30 Gy or less comprised most
UTC patients, only 1-year, but not median, survival improved compared to l
iterature controls.